IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — VEON

Balance Sheet

(in billions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q3 2021Q2 2021
Cash & Equivalents1.280.862.462.341.501.19
Inventory0.020.020.020.120.110.12
Total Current Assets----------2.50
Goodwill0.380.350.351.251.412.68
Total Non-current Assets5.824.944.8912.0010.0412.25
Total Assets8.467.3313.0117.6915.0214.75
Total Current Liabilities2.993.073.526.14--4.48
Total Non-current Liabilities3.943.083.889.628.919.05
Total Liabilities*6.976.2012.0216.1313.7513.53
Total Stockholder Equity1.501.130.991.561.281.23

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q3 2021Q2 2021
Total Revenue1.091.030.922.012.012.07
Selling, General & Admin0.460.450.390.670.630.68
Operating Income0.820.280.240.370.410.37
Pretax Income0.680.140.190.200.240.22
Tax Provision0.070.050.040.080.110.09
Net Income0.610.090.270.180.200.13
Basic EPS0.340.040.140.080.090.06
Diluted EPS0.340.040.140.080.090.06

Cash Flow Statement

(in billions USD)
MetricQ2 2021
Operating Cash Flow1.20
Investing Cash Flow(1.13)
Financing Cash Flow(0.55)